Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race

Journal of Clinical Pharmacology

Volumn 41, Issue 11, 2001, Pages 1180-1194

  Magee, M H ^a   Blum, R A ^a   Lates, C D ^a   Jusko, W J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; PREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CAUCASIAN; DISTRIBUTION VOLUME; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; GENDER; HELPER CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; IC 50; LUTEAL PHASE; LYMPHOCYTE COUNT; MALE; NEGRO; NEUTROPHIL; NORMAL HUMAN; PHARMACODYNAMICS; RACE DIFFERENCE; SEX DIFFERENCE; STATISTICAL ANALYSIS; SUPPRESSOR CELL; ULTRAFILTRATION;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-INFLAMMATORY AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUTROPHILS; PREDNISOLONE; SEX FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 0034770387     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700122012733     Document Type: Article

References (46)

1. Gender effects in pharmacokinetics and pharmacodynamics
2. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
3. Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs
4. Pharmacokinetics of caffeine during and after pregnancy
5. Aging of women alters Sverapamil pharmacokinetics and pharmacodynamics
6. Prednisolone disposition and protein binding in oral contraceptive users
7. Sex differences in peripheral vascular adrenergic receptors
8. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs
9. Experimental pain in healthy human subjects: Gender differences in nociception and in response to ibuprofen
10. Ethnic differences in drug disposition and responsiveness
11. Influence of race or ethnicity on pharmacokinetics of drugs
12. Racial differences in the pharmacokinetics of methylprednisolone in black and white renal transplant recipients
13. Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients
14. Do African Americans display a diminished response to glucocorticoids?
15. Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients
16. Causes of renal allograft loss in black vs. white transplant recipients in the cyclosporine era
17. Alterations in prednisolone disposition as a result of time of administration, gender and dose
18. Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism
19. Pharmacokinetic and adrenal interactions of IL-10 and prednisone in healthy volunteers
20. Corticosteroids
21. Corticosteroid analysis in biological fluids by high-performance liquid chromatography
22. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma
23. Comparison of four basic mo dels of indirect pharmacodynamic responses
24. Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition
25. Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models
26. Circadian changes of T lymphocyte subsets in human peripheral blood
27. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking
28. The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo
29. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes
30. Glucocorticosteroid therapy: Mechanisms of action and clinical considerations
31. Regulation of Lselectin and CD18 on bovine neutrophils by glucocorticoids: Effects of cortisol and dexamethasone
32. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms
33. Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine
34. CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4* 1B5′-promoter region polymorphism
35. Sex hormones, immune responses, and autoimmune disease: Mechanism of a sex hormone action
36. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1
37. Increased PGE2 from human monocytes isolated in the luteal phase of the menstrual cycle. Implications for immunity?
38. Variation in natural killer activity in peripheral blood during the menstrual cycle
39. Diurnal sleep/wake-related immune functions during the menstrual cycle of healthy young women
40. Cyclic variations in white cell subpopulations in the human menstrual cycle: Correlations with progesterone and estradiol
41. Pharmacoimmunodynamic interactions of interleukin-10 and prednisone in healthy volunteers
42. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man
43. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects
44. Prednisolone binding to albumin and transcortin in the presence of cortisol
45. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena